Yüklüyor......

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

BACKGROUND: The anti-interleukin (IL) 6 receptor antibody tocilizumab inhibits signalling of IL6, a key cytokine in rheumatoid arthritis (RA) pathogenesis. OBJECTIVE: To evaluate through the AMBITION study the efficacy and safety of tocilizumab monotherapy versus methotrexate in patients with active...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jones, G, Sebba, A, Gu, J, Lowenstein, M B, Calvo, A, Gomez-Reino, J J, Siri, D A, Tomšič, M, Alecock, E, Woodworth, T, Genovese, M C
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747519/
https://ncbi.nlm.nih.gov/pubmed/19297346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2008.105197
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!